PE20061112A1 - PHARMACEUTICAL COMPOSITIONS INCLUDING DROSPIRENONE, ETHINYLESTRADIOL AND SURFACTING AGENT - Google Patents

PHARMACEUTICAL COMPOSITIONS INCLUDING DROSPIRENONE, ETHINYLESTRADIOL AND SURFACTING AGENT

Info

Publication number
PE20061112A1
PE20061112A1 PE2006000018A PE2006000018A PE20061112A1 PE 20061112 A1 PE20061112 A1 PE 20061112A1 PE 2006000018 A PE2006000018 A PE 2006000018A PE 2006000018 A PE2006000018 A PE 2006000018A PE 20061112 A1 PE20061112 A1 PE 20061112A1
Authority
PE
Peru
Prior art keywords
ethinylestradiol
pharmaceutical compositions
compositions including
drospirenone
surfacting
Prior art date
Application number
PE2006000018A
Other languages
Spanish (es)
Inventor
Gustavo Alejandro Andrade
Carlos Daniel Zanetti
Original Assignee
Gador Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gador Sa filed Critical Gador Sa
Publication of PE20061112A1 publication Critical patent/PE20061112A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) DROSPIRENONA CARACTERIZADA PORQUE EL 95% PRESENTEN UN TAMANO DE PARTICULA INFERIOR A 100 um , EL 26% PRESENTE UN TAMANO DE PARTICULA INFERIOR A 20 um; B) ETINILESTRADIOL EN UN RANGO DE 20-50 ug; C) UN AGENTE SURFACTANTE NO IONICO SELECCIONADO ENTRE POLISORBATO 20, POLISORBATO 60, TWEEN 80, ENTRE OTROS; D) DILUYENTES, DISGREGANTES, LUBRICANTES, AGLUTINANTES, ENTRE OTROS. REFERIDA TAMBIEN A UNA PROCEDIMIENTO DE PREPARACION. DICHA COMPOSICION PROPORCIONA ESTABILIDAD FISICOQUIMICA UTILES EN EL TRATAMIENTO DE LA ANTICONCEPCIONIT REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES: A) DROSPIRENONE CHARACTERIZED BECAUSE 95% PRESENT A PARTICLE SIZE LESS THAN 100 um, 26% PRESENT A PARTICLE SIZE LESS THAN 20 um; B) ETHINYLESTRADIOL IN A RANGE OF 20-50 ug; C) A NON-IONIC SURFACTING AGENT SELECTED FROM POLYSORBATE 20, POLYSORBATE 60, TWEEN 80, AMONG OTHERS; D) THINNERS, DISGREGANTS, LUBRICANTS, BINDERS, AMONG OTHERS. ALSO REFERRED TO A PREPARATION PROCEDURE. SUCH COMPOSITION PROVIDES USEFUL PHYSICOCHEMICAL STABILITY IN THE TREATMENT OF CONTRACEPTION

PE2006000018A 2004-12-28 2006-01-03 PHARMACEUTICAL COMPOSITIONS INCLUDING DROSPIRENONE, ETHINYLESTRADIOL AND SURFACTING AGENT PE20061112A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP040104928 AR047782A1 (en) 2004-12-28 2004-12-28 SOLID PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A COMBINATION OF DROSPIRENONE, ETHYLYNESTRADIOL AND AN APPROPRIATE SURFACTING AGENT THAT PRESENTS A HOMOGENEITY OF CONTENT AND SPEED OF DISSOLVED INSURANCE FOR NON-MICRONIZED DRUG, PROCEDURE FOR PREPARATION OF USE

Publications (1)

Publication Number Publication Date
PE20061112A1 true PE20061112A1 (en) 2006-11-27

Family

ID=36607162

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000018A PE20061112A1 (en) 2004-12-28 2006-01-03 PHARMACEUTICAL COMPOSITIONS INCLUDING DROSPIRENONE, ETHINYLESTRADIOL AND SURFACTING AGENT

Country Status (4)

Country Link
AR (1) AR047782A1 (en)
CO (1) CO5770093A1 (en)
PE (1) PE20061112A1 (en)
UY (1) UY29227A1 (en)

Also Published As

Publication number Publication date
AR047782A1 (en) 2006-02-22
UY29227A1 (en) 2005-12-30
CO5770093A1 (en) 2007-06-29

Similar Documents

Publication Publication Date Title
PE20070216A1 (en) NEW PHARMACEUTICAL COMPOSITIONS INCLUDING LEVETIRACETAM AND PROCESS FOR ITS PREPARATION
PE20070208A1 (en) ORAL CONTRACEPTION WITH TRIMEGESTONE
EP1476138B8 (en) Modified release formulations of at least one form of tramadol
RS51569B (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
RS51563B (en) Pharmaceutical compositions containing rosuvastatin calcium
WO2007100382A3 (en) Orally administrable gallium compositions and method of use
IL216194A0 (en) Pharmaceutical compositions of a neuroactive steroid and uses thereof
ATE521343T1 (en) COMPOSITIONS OF RASAGILIN THAT DISSOLVE IN THE MOUTH
PE20080273A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A PROGESTAGEN, A ESTROGEN AND A TETRAHYDROPHOLIC ACID
MX336930B (en) Ganaxolone formulations and methods for the making and use thereof.
AU2003304237A1 (en) Gel-stabilized nanoparticulate active agent compositions
WO2007022023A3 (en) Film forming spreading agents
AR057060A1 (en) TANAPROGET COMPOSITIONS CONTAINING ETHYL ESTRADIOL
GT200600307A (en) DOSAGE METHODS OF ORAL DELAYED ORAL DISPOSAL OF OR-DEMETILVENLAFAXIN SUCCINATE
BR0316310A (en) Pharmaceutical compositions having a modified vehicle
NZ602538A (en) Thermogelling anaesthetic compositions
JP2011503007A5 (en)
JP2008515980A5 (en)
MX2010005013A (en) Intranasal compositions.
CO5160322A1 (en) ANTIPERSPIRING COMPOSITIONS
JP2005513006A5 (en)
UA95088C2 (en) Composition comprising at least one anticancer drug and at least one polymer and reducing chemotherapy-induced alopecia, process for the preparation thereof
WO2009039157A3 (en) Orlistat pharmaceutical formulations
WO2008062475A3 (en) Pharmaceutical compositions of ursodiol
TW200612962A (en) Estriol and estetrol prodrugs

Legal Events

Date Code Title Description
FC Refusal